Andrew M. Ibrahim

Phoenix Contact (United States), University of Michigan–Ann Arbor

Papers

Total Citations

182

H-Index

About

Dr. Andrew M. Ibrahim is a health services researcher and surgeon whose work critically examines the intersection of technology, policy, and patient safety in modern surgery. His research primarily focuses on the adoption and regulation of robotic surgery, with a particular emphasis on transparency, industry influence, and patient outcomes. In his landmark 2013 study, "Underreporting of Robotic Surgery Complications" (111 citations), Dr. Ibrahim revealed significant gaps in the FDA’s adverse event reporting system, demonstrating that device-related complications were systematically underreported—a finding that reshaped conversations around surgical device surveillance. His earlier work, "Robotic Surgery Claims on United States Hospital Websites" (69 citations), exposed how hospitals often marketed robotic surgery with exaggerated or unsubstantiated benefits, raising critical questions about informed patient consent. Most recently, his 2025 study on "Industry Payments and Sentiments Toward Robotic Surgery Among US Physicians" (2 citations) provides timely evidence linking financial relationships with physicians’ positive perceptions of robotic platforms. Through rigorous, policy-relevant research, Dr. Ibrahim has become a leading voice advocating for evidence-based surgical innovation, earning recognition for holding both industry and institutions accountable to the highest standards of patient safety and transparency.